The common LRRK2 mutation G2019S enhances NSF kinase activity, potentially disrupting SV dynamics through abnormal phosphorylation of NSF and contributing to the manifestation of Parkinson’s symptoms (Belluzzi et al., 2016). The gene discussed is LRRK2; the disease is Parkinson disease.